pirenzepine has been researched along with Diseases in Twins in 1 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
Diseases in Twins: Disorders affecting TWINS, one or both, at any age.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mata, I | 1 |
| Madoz, V | 1 |
| Arranz, MJ | 1 |
| Sham, P | 1 |
| Murray, RM | 1 |
1 other study available for pirenzepine and Diseases in Twins
| Article | Year |
|---|---|
Olanzapine: concordant response in monozygotic twins with schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Diseases in Twins; Female; Humans; Middle Aged; Olanzapine; P | 2001 |